Citations 2
Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma
Haefner, Matthias F. , Bougatf, Nina , Mielke, Thomas, Tonndorf‐Martini, Eric, König, Laila , Rwigema, Jean‐Claude M. , Simone, Charles B. , Uhlmann, Lorenz , Eichhorn, Florian , Winter, H. , Grosch, Heidrun, Haberer, Thomas, Herfarth, Klaus , Rieken, Stefan , Simone, Charles B , Verma, Vivek , Debus, Jürgen
Acta Oncologica | September 28, 2018 | Volume: 57 | Issue: 12 | Pages: 1713-1720
A randomized, open-label, phase 2 study of emibetuzumab plus erlotinib (LY+E) and emibetuzumab monotherapy (LY) in patients with acquired resistance to erlotinib and MET diagnostic positive (MET Dx+) metastatic NSCLC.
Camidge, D. Ross , Demedts, Ingel , Grosch, Heidrun, Mercurio, Jean-Pierre Di , Molina, Julian R. , Bepler, Gerold , Lewanski, C., Wijayawardana, Sameera R. , Wang, Xuejing Aimee , Morán, Teresa , Mileham, Kathryn Finch , Juan, Óscar , Goldman, Jonathan W. , Park, Keunchil , Wallin, Johan Erik , Wacheck, Volker , Smit, Egbert F
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 9070-9070